Key result
ICON1 evaluates 1-year ischemic and bleeding outcomes in patients aged 75 and older with NSTEACS.
Population
Older patients with non-ST-elevation acute coronary syndrome planned for coronary angiogram or percutaneous…
Design
Cohort, Operator blinded to VH-IVUS and OCT data during the procedure
Follow-up
30 days and 1 year
Authors
Loading...
The ICON1 study is a prospective observational cohort designed to identify predictors of adverse outcomes and develop a risk prediction tool for patients aged ≥75 years undergoing invasive management for NSTEACS.
Observational (n=300)
Yes
The ICON1 study is a prospective observational cohort designed to identify predictors of adverse outcomes and develop a risk prediction tool for patients aged ≥75 years undergoing invasive management for NSTEACS.
Kunadian et al. (2016) conducted an observational in Non-ST-elevation acute coronary syndrome (NSTEACS) (n=300). Frailty and comorbid status was evaluated on Composite of death, MI, stroke, repeat, unplanned revascularisation and BARC-defined bleeding (type 2 or greater) at 1 year. The ICON1 study is an ongoing prospective observational study designed to identify predictors of adverse cardiovascular outcomes at 1 year in patients aged 75 years and older with NSTEACS.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: